Skip to main content

Table 2 Patient overview with details about treatment, tumour location and bone resection

From: Clinical validation of a commercially available deep learning software for synthetic CT generation for brain

Patient Glioma (G)/metastasis (M) Prescribed dose [Gy] Beam configuration PTVvol [cc] Bone resected (yes/no) Max d* [mm] Tumour location
1 M 25.0 2 arcs 31 N Right thalamus
2 G 34.0 2 arcs, NC 408 Y 10 Right frontal/temporal
3 M 30.0 1 arc 5 Y 10 Left frontal
4 M 30.0 3 arcs, NC 10 Y** 10 Right occipital
5 G 40.05 1 arc 181 Y 10 Left frontal/parietal
6 G 40.05 2 arcs 448 Y 10 Right temporal
7 G 40.05 2 half arcs 186 Y 10 Left occipital/temporal
8*** M 30.0 2 arcs 21 Y 20 Cerebellum
9 M 30.0 1 arc 41 N Right frontal
10*** M 30.0 2 arcs 2 N Left occipital
11 G 60.0 4 arcs, NC 439 Y 10 Bilateral frontal/temporal
12 G 34.0 2 half arcs 314 Y 10 Left frontal/temporal
13 M 24.0 2 arcs 63 N Left temporal
14 G 60.0 2 arcs 179 Y 10 Left frontal/temporal
15 G 60.0 2 half arcs 168 Y 10 Left temporal/occipital
16*** G 60.0 2 arcs, NC 430 Y 30 Left hemisphere
17 M 30.0 2 arcs 16 N Left parietal
18 G 25.0 2 arcs 318 Y 10 Left hemisphere
19 M 30.0 2 arcs, NC 21 Y** 10 Right occipital
20 M 30.0 3 arcs, NC 25 N - Right parietal
  1. Patients identified as having targets in complex regions were number 2, 6, 8, 11, 14, 16 and 18
  2. *Max d refers to the maximum diameter of the bone resection. One patient may have more than one resection area, in which case the largest one is presented
  3. **Bone resection from previous surgery, not adjacent to the PTV evaluated in this study
  4. ***Three of the patients are presented in Fig. 1 to represent the range of tumour locations and sizes; patient 10 corresponds to patient A, patient 8 corresponds to patient B and patient 16 corresponds to patient C